Risk score and clinicopathological characteristics
Breast cancer, T stage
BREAST CANCER
Breast cancer patients in training set were also assigned into subgroups by clinicopathological characteristics [including age, T stage, N stage, M stage, TNM stage, status of ER, PR, HER2, and menopause (Pre: <6 months since last menstrual period AND no prior bilateral ovariectomy AND not on estrogen replacement; Post: prior bilateral ovariectomy OR > 12 months since last menstrual period with no prior hysterectomy)]. Then, the associations between risk score and clinical features were identified, and the predictive value of SERGs signature in subgroups were also presented based on various clinical characteristics.